Ambrx vs ONCOMATRYX
Ambrx vs ONCOMATRYX, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Ambrx is on 35/100 and ONCOMATRYX on 50/100.
Where each one leads
Ambrx
- domain rating: 36/100 against 26/100
- funding raised: $462M against $107M
ONCOMATRYX
- our overall score: 50/100 against 35/100
- agent readiness: 36/100 against 22/100
At a glance
| Measure | Ambrx | ONCOMATRYX |
|---|---|---|
| What it is | Clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) for cancer treatment. | Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies. |
| Category | Biotechnology, Drug Discovery, Oncology, Antibody-Drug Conjugates (ADCs) | Biotechnology, Pharmaceuticals, Healthcare, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | hardware | services | marketplace | platform | Services |
| Founded | 2003 | 2009 |
| Headquarters | San Diego, United States | Derio, Spain |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Ambrx | ONCOMATRYX |
|---|---|---|
| Employees | Not published | 36 |
| Total funding | $462M | $107M |
| Latest round | ATM | Funding Round |
| LinkedIn followers | Not published | 5,170 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Ambrx | ONCOMATRYX |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 35/100 | 50/100 |
| Traction | 40/100 | 56/100 |
| Team | 70/100 | 30/100 |
| Community | 12/100 | Not published |
| Search visibility | Not published | 37/100 |
| Quality | 30/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (22/100) | F (36/100) |
| Domain ratingLink authority, 0-100 | 36/100 | 26/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Ambrx | ONCOMATRYX |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4 |
Ambrx vs ONCOMATRYX: common questions
Which is better, Ambrx or ONCOMATRYX?
On our 0-100 score ONCOMATRYX rates higher (50/100 against 35/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Ambrx and ONCOMATRYX compare on the numbers?
Ambrx leads on domain rating (36/100 against 26/100), funding raised ($462M against $107M). ONCOMATRYX leads on our overall score (50/100 against 35/100), agent readiness (36/100 against 22/100).
Read the full Ambrx review and pricing or the ONCOMATRYX review and pricing. You can also browse other Ambrx alternatives we track.